Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,777 | 13,721 | 27,850 | 10,454 | 9,279 |
| Marketable Securities | 76,500 | 49,084 | 28,510 | 47,217 | 50,748 |
| Receivables | 344 | 238 | 200 | 298 | 197 |
| TOTAL | $94,839 | $64,454 | $57,978 | $58,857 | $60,944 |
| Non-Current Assets | |||||
| PPE Net | 656 | 1,402 | 1,845 | 1,576 | 1,695 |
| Investments And Advances | 7,711 | 0 | 0 | 6,043 | 12,535 |
| Intangibles | 16,659 | 16,659 | 36,397 | 36,397 | 2,117 |
| Other Non-Current Assets | 960 | 750 | 354 | 230 | 455 |
| TOTAL | $25,986 | $18,811 | $38,596 | $44,246 | $16,802 |
| Total Assets | $120,825 | $83,265 | $96,574 | $103,103 | $77,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,246 | 824 | 439 | 689 | 533 |
| Accrued Expenses | 9,158 | 7,597 | 4,211 | 3,435 | 3,933 |
| Other current liabilities | 355 | 352 | 145 | 283 | 194 |
| TOTAL | $11,759 | $8,773 | $4,795 | $4,407 | $4,660 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30 | 135 | 1,136 | 522 | 1,097 |
| TOTAL | $30 | $135 | $8,044 | $7,430 | $1,536 |
| Total Liabilities | $11,789 | $8,908 | $12,839 | $11,837 | $6,196 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,317 | 49,222 | 15,830 | 17,054 | 11,791 |
| Common Shares | 353,852 | 353,849 | 353,856 | 353,856 | 353,854 |
| Retained earnings | -629,268 | -572,334 | -514,629 | -482,048 | -432,085 |
| Other shareholders' equity | -5,185 | -5,080 | -5,064 | -5,091 | -5,051 |
| TOTAL | $109,036 | $74,357 | $83,735 | $91,266 | $71,550 |
| Total Liabilities And Equity | $120,825 | $83,265 | $96,574 | $103,103 | $77,746 |